118 related articles for article (PubMed ID: 17351653)
21. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
Sun L; Ke Y; Zhu CY; Tang N; Tian DK; Gao YH; Zheng JP; Bian K
Chin Med J (Engl); 2008 Nov; 121(22):2305-11. PubMed ID: 19080338
[TBL] [Abstract][Full Text] [Related]
22. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
23. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
[TBL] [Abstract][Full Text] [Related]
24. High glucose enhances angiotensin-II-mediated peroxisome proliferation-activated receptor-gamma inactivation in human coronary artery endothelial cells.
Min Q; Bai YT; Jia G; Wu J; Xiang JZ
Exp Mol Pathol; 2010 Feb; 88(1):133-7. PubMed ID: 19796634
[TBL] [Abstract][Full Text] [Related]
25. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase.
Sarr M; Chataigneau M; Martins S; Schott C; El Bedoui J; Oak MH; Muller B; Chataigneau T; Schini-Kerth VB
Cardiovasc Res; 2006 Sep; 71(4):794-802. PubMed ID: 16822492
[TBL] [Abstract][Full Text] [Related]
26. Effects of pioglitazone on nitric oxide bioavailability measured using a catheter-type nitric oxide sensor in angiotensin II-infusion rabbit.
Imanishi T; Kuroi A; Ikejima H; Kobayashi K; Mochizuki S; Goto M; Yoshida K; Akasaka T
Hypertens Res; 2008 Jan; 31(1):117-25. PubMed ID: 18360026
[TBL] [Abstract][Full Text] [Related]
27. Beneficial and deleterious effects of rosiglitazone on hypertension development in spontaneously hypertensive rats.
Wu L; Wang R; De Champlain J; Wilson TW
Am J Hypertens; 2004 Sep; 17(9):749-56. PubMed ID: 15363815
[TBL] [Abstract][Full Text] [Related]
28. The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy.
Arora MK; Reddy K; Balakumar P
Eur J Pharmacol; 2010 Jun; 636(1-3):137-44. PubMed ID: 20347778
[TBL] [Abstract][Full Text] [Related]
29. PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia.
Hennuyer N; Tailleux A; Torpier G; Mezdour H; Fruchart JC; Staels B; Fiévet C
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1897-902. PubMed ID: 15994444
[TBL] [Abstract][Full Text] [Related]
30. PPAR activation: a new target for the treatment of hypertension.
Leibovitz E; Schiffrin EL
J Cardiovasc Pharmacol; 2007 Aug; 50(2):120-5. PubMed ID: 17703128
[TBL] [Abstract][Full Text] [Related]
31. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
[TBL] [Abstract][Full Text] [Related]
32. Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.
Tawfik A; Sanders T; Kahook K; Akeel S; Elmarakby A; Al-Shabrawey M
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):878-84. PubMed ID: 18806296
[TBL] [Abstract][Full Text] [Related]
33. Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism.
Ceolotto G; Gallo A; Papparella I; Franco L; Murphy E; Iori E; Pagnin E; Fadini GP; Albiero M; Semplicini A; Avogaro A
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2627-33. PubMed ID: 17916771
[TBL] [Abstract][Full Text] [Related]
34. Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice.
Virdis A; Iglarz M; Neves MF; Amiri F; Touyz RM; Rozen R; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1352-7. PubMed ID: 12829522
[TBL] [Abstract][Full Text] [Related]
35. Combined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions.
Escudero P; Martinez de Marañón A; Collado A; Gonzalez-Navarro H; Hermenegildo C; Peiró C; Piqueras L; Sanz MJ
Antioxid Redox Signal; 2015 Apr; 22(11):901-20. PubMed ID: 25602514
[TBL] [Abstract][Full Text] [Related]
36. CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves' and normal thyrocytes.
Antonelli A; Ferrari SM; Frascerra S; Pupilli C; Mancusi C; Metelli MR; Orlando C; Ferrannini E; Fallahi P
J Clin Endocrinol Metab; 2010 Dec; 95(12):E413-20. PubMed ID: 20810571
[TBL] [Abstract][Full Text] [Related]
37. Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo.
Egerod FL; Nielsen HS; Iversen L; Thorup I; Storgaard T; Oleksiewicz MB
Biomarkers; 2005; 10(4):295-309. PubMed ID: 16240504
[TBL] [Abstract][Full Text] [Related]
38. Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Protects From Angiotensin II-Induced Endothelial Dysfunction in Adult Offspring Born From Pregnancies Complicated by Hypertension.
Nair AR; Silva SD; Agbor LN; Wu J; Nakagawa P; Mukohda M; Lu KT; Sandgren JA; Pierce GL; Santillan MK; Grobe JL; Sigmund CD
Hypertension; 2019 Jul; 74(1):173-183. PubMed ID: 31104564
[TBL] [Abstract][Full Text] [Related]
39. Effects of fenofibrate, a PPAR-α ligand, on the haemodynamics of glycerol-induced renal failure in rats.
Adedapo AA; Oyekan AO
Hum Exp Toxicol; 2013 Mar; 32(3):323-31. PubMed ID: 22859660
[TBL] [Abstract][Full Text] [Related]
40. Protection of endothelial cells against Ang II-induced impairment: Involvement of both PPARα and PPARγ via PI3K/Akt pathway.
Shan H; Zhang S; Wei X; Li X; Qi H; He Y; Liu A; Luo D; Yu X
Clin Exp Hypertens; 2016; 38(7):571-577. PubMed ID: 27650941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
